LAURA DOWNEY: Open Payments
NPI 1215932553 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 24 payments from 7 companies in 2025. Trend: 2023 $605 · 2024 $250 · 2025 $514
Food & beverage: $480Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $178 |
| GENZYME CORPORATION | 5 | $169 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| Amgen Inc. | 1 | $34 |
| Stryker Corporation | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: DUPIXENT, NUCALA, XPRESS LOPROFILE, TEZSPIRE, TAKHZYRO.
Industry payments across NJ — which companies pay providers there.
